The First International Congress on Women’s Health and Unsafe Abortion, Thailand

Gynuity staff and colleagues organized and participated in a panel on medical abortion at this international congress.

How pills can make abortion care more accessible to women
Chair: Dr. Beverly Winikoff, President, Gynuity Health Projects, USA

• Ms. Rasha Dabash, Gynuity Health Projects – “Advancements in the Treatment of Abortion Complications: Incorporating an Evidence-based Technology into Services”

• Dr. Anadil Alam, Health System and Economics Unit, HSID, ICDDRB, Bangladesh – “Menstrual Regulation Using Mifepristone and Misoprostol: A New Method for Bangladesh”

• Ms. Jennifer Blum, Gynuity Health Projects – “Estimating the Advantages of Adding Mifepristone to Misoprostol-only Regimens for Medical Abortion in the First Trimester”

• Nguyen thi Nhu Ngoc MD, MSc, Center for Research and Consultancy in Reproductive Health, Vietnam – “Estimating the Advantages of Adding Mifepristone to Misoprostol-only Regimens for Medical Abortion in the Second Trimester”

• Dr Suchitra Dalvie, ASAP, India – “Challenges to Maximizing Use of Medical Abortion in India”